Shenzhen Edge Medical Launches Hong Kong IPO to Raise HK$1.2 Billion

MT Newswires Live

2025/12/30

Shenzhen Edge Medical (HKG:2675) launched its Hong Kong initial public offering on Tuesday, aiming to raise about HK$1.20 billion.

The medical technology company is offering 27,722,200 H-shares at an offer price of HK$43.24 per share, according to a Tuesday Hong Kong bourse filing.

The offering comprises 2.8 million shares for Hong Kong investors and 24.9 million shares for international investors, subject to reallocation and the overallotment option.

The company secured 15 cornerstone investors, which committed to subscribing to $75 million worth of IPO shares.

The allocation results are expected to be announced on Jan. 7, ahead of the company's trading debut on Jan. 8.

Net proceeds will be used primarily for research and development activities and to commercialize the company's products.

Morgan Stanley Asia, GF Securities (Hong Kong), China International Capital Corporation Hong Kong Securities, CLSA, and CMBC Securities are the joint bookrunners of the IPO.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2595275274"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2595275274\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2595275274?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-30 09:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2595275274","market":"sg","top_or_hot":-1,"title":"Shenzhen Edge Medical Launches Hong Kong IPO to Raise HK$1.2 Billion","media":"MT Newswires Live","content":"<html><body><p> Shenzhen Edge Medical (HKG:2675) launched its Hong Kong initial public offering on Tuesday, aiming to raise about HK$1.20 billion.</p><p>The medical technology company is offering 27,722,200 H-shares at an offer price of HK$43.24 per share, according to a Tuesday Hong Kong bourse filing.</p><p>The offering comprises 2.8 million shares for Hong Kong investors and 24.9 million shares for international investors, subject to reallocation and the overallotment option.</p><p>The company secured 15 cornerstone investors, which committed to subscribing to $75 million worth of IPO shares.</p><p>The allocation results are expected to be announced on Jan. 7, ahead of the company's trading debut on Jan. 8.</p><p>Net proceeds will be used primarily for research and development activities and to commercialize the company's products.</p><p>Morgan Stanley Asia, <a href=\"https://laohu8.com/S/GFSEF\">GF Securities</a> (Hong Kong), China International Capital Corporation Hong Kong Securities, CLSA, and CMBC Securities are the joint bookrunners of the IPO.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shenzhen Edge Medical Launches Hong Kong IPO to Raise HK$1.2 Billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShenzhen Edge Medical Launches Hong Kong IPO to Raise HK$1.2 Billion\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-12-30 09:51</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Shenzhen Edge Medical (HKG:2675) launched its Hong Kong initial public offering on Tuesday, aiming to raise about HK$1.20 billion.</p><p>The medical technology company is offering 27,722,200 H-shares at an offer price of HK$43.24 per share, according to a Tuesday Hong Kong bourse filing.</p><p>The offering comprises 2.8 million shares for Hong Kong investors and 24.9 million shares for international investors, subject to reallocation and the overallotment option.</p><p>The company secured 15 cornerstone investors, which committed to subscribing to $75 million worth of IPO shares.</p><p>The allocation results are expected to be announced on Jan. 7, ahead of the company's trading debut on Jan. 8.</p><p>Net proceeds will be used primarily for research and development activities and to commercialize the company's products.</p><p>Morgan Stanley Asia, <a href=\"https://laohu8.com/S/GFSEF\">GF Securities</a> (Hong Kong), China International Capital Corporation Hong Kong Securities, CLSA, and CMBC Securities are the joint bookrunners of the IPO.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02675","symbol_name":"精鋒醫療-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2595275274","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2595275274","pubTimestamp":1767059516,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shenzhen Edge Medical  launched its Hong Kong initial public offering on Tuesday, aiming to raise about HK$1.20 billion.The medical technology company is offering 27,722,200 H-shares at an offer price of HK$43.24 per share, according to a Tuesday Hong Kong bourse filing.The offering comprises 2.8 million shares for Hong Kong investors and 24.9 million shares for international investors, subject to reallocation and the overallotment option.The company secured 15 cornerstone investors, which committed to subscribing to $75 million worth of IPO shares.The allocation results are expected to be announced on Jan. 7, ahead of the company's trading debut on Jan. 8.Net proceeds will be used primarily for research and development activities and to commercialize the company's products.Morgan Stanley Asia, GF Securities , China International Capital Corporation Hong Kong Securities, CLSA, and CMBC Securities are the joint bookrunners of the IPO.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02675":"精锋医疗-B"},"translate_title":"深圳边缘医疗启动香港IPO募资12亿港元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02675":0.9},"content_text":"Shenzhen Edge Medical (HKG:2675) launched its Hong Kong initial public offering on Tuesday, aiming to raise about HK$1.20 billion.The medical technology company is offering 27,722,200 H-shares at an offer price of HK$43.24 per share, according to a Tuesday Hong Kong bourse filing.The offering comprises 2.8 million shares for Hong Kong investors and 24.9 million shares for international investors, subject to reallocation and the overallotment option.The company secured 15 cornerstone investors, which committed to subscribing to $75 million worth of IPO shares.The allocation results are expected to be announced on Jan. 7, ahead of the company's trading debut on Jan. 8.Net proceeds will be used primarily for research and development activities and to commercialize the company's products.Morgan Stanley Asia, GF Securities (Hong Kong), China International Capital Corporation Hong Kong Securities, CLSA, and CMBC Securities are the joint bookrunners of the IPO.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}